![Mahalakshmi Radhakrishnan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mahalakshmi Radhakrishnan
Direktör/Styrelseledamot på
ENTRADA THERAPEUTICS, INC.
Förmögenhet: - $ per 2026-05-31
Profil
Mahalakshmi Radhakrishnan is currently an Independent Director at Entrada Therapeutics, Inc. and Candel Therapeutics, Inc. since 2025.
Serving as Director at PhRMA Foundation since 2022 and at Minovia Therapeutics Ltd. since 2023.
Executive Partner & Private Equity at Sofinnova Investments, Inc. since 2024.
Former roles include Independent Director at Alto Neuroscience, Inc. from 2024 to 2025, Independent Director at biOasis Technologies, Inc. from 2017 to 2018, Executive Director & Head-Therapeutic Area at Bristol-Myers Squibb Holdings Pharma LLC from 2009 to 2013, Vice President at Biogen, Inc. from 2013 to 2016, Global Head-Medical & Primary Care Business Unit at Sanofi from 2016 to 2019, Senior Vice President & Head-Worldwide Medical at Bioverativ Therapeutics, Inc., and Chief Medical Officer & Group Senior VP at Biogen, Inc. from 2020 to 2024.
Education includes a doctorate from Peoples' Friendship University of Russia.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-23 | 0 ( -.--% ) | - $ | 2026-05-31 | |
| 2026-06-10 | 0 ( -.--% ) | - $ | 2026-05-31 |
Aktiva positioner av Mahalakshmi Radhakrishnan
| Företag | Position | Start |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2025-06-01 |
| CANDEL THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2025-06-04 |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Direktör/Styrelseledamot | 2022-11-29 |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Direktör/Styrelseledamot | 2023-01-05 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Privat kapitalinvesterare | 2024-08-01 |
Tidigare kända positioner av Mahalakshmi Radhakrishnan
| Företag | Position | Slut |
|---|---|---|
| ALTO NEUROSCIENCE, INC. | Direktör/Styrelseledamot | 2025-05-13 |
| BIOGEN INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-03-01 |
| SANOFI | Företagsledare/Principal | 2019-01-01 |
| BIOASIS TECHNOLOGIES INC. | Direktör/Styrelseledamot | 2018-07-27 |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Mahalakshmi Radhakrishnans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
70
Första gradens relationer
12
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Peoples' Friendship University of Russia
 Peoples' Friendship University of Russia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
biOasis Technologies, Inc.
 biOasis Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic drug delivery for the treatment of neurological diseases and disorders | Health Technology |
Bristol-Myers Squibb Holdings Pharma LLC
 Bristol-Myers Squibb Holdings Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Health Technology |
Alto Neuroscience, Inc.
 Alto Neuroscience, Inc. BiotechnologyHealth Technology Engages in psychiatric drug development | Health Technology |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
